C07D 265/02
1,2-oxazines
Official title: 1,2-Oxazines; Hydrogenated 1,2-oxazines
C07D265/02 (1,2-oxazines) appears on 93 US grants and 90 published applications in this corpus.
Search patents in C07D- Granted patents
- 93
- Published applications
- 90
- Assignees
- 65
- Inventors
- 390
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 0 |
| 2002 | 4 | 8 |
| 2003 | 6 | 10 |
| 2004 | 2 | 9 |
| 2005 | 5 | 7 |
| 2006 | 3 | 6 |
| 2007 | 5 | 5 |
| 2008 | 5 | 2 |
| 2009 | 1 | 4 |
| 2010 | 5 | 5 |
| 2011 | 1 | 2 |
| 2012 | 1 | 1 |
| 2013 | 2 | 1 |
| 2014 | 1 | 2 |
| 2015 | 2 | 1 |
| 2016 | 1 | 3 |
| 2017 | 0 | 2 |
| 2018 | 1 | 2 |
| 2019 | 3 | 3 |
| 2020 | 1 | 1 |
| 2021 | 0 | 3 |
| 2022 | 4 | 2 |
| 2023 | 0 | 1 |
| 2024 | 2 | 5 |
| 2025 | 3 | 4 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Enantioselective process30 Dec 2025US 12,509,417 B2Syngenta Crop Protection AG
- Herbicidal compounds25 Nov 2025US 12,479,804 B2Syngenta Crop Protection AG
- Nitrogen-containing heterocyclic compound having NRF2 activation effect14 Oct 2025US 12,441,735 B2Chugai Seiyaku Kabushiki Kaisha
- Piperlongumine analogues and uses thereof10 Sep 2024US 12,084,423 B2BioVentures, LLC
- Arylamide derivative having antitumor activity23 Apr 2024US 11,964,950 B2Chugai Seiyaku Kabushiki Kaisha
- Herbicidal composition containing difluorobutenoic acid amide compound8 Jan 2026US 2026/0007131 A1Ishihara Sangyo Kaisha, Ltd.
- Substituted tetracycline compounds25 Dec 2025US 2025/0388531 A1Paratek Pharmaceuticals, Inc.
- Piperidinone derivative or salt thereof, harmful organism control agent containing said compound, and method for using same12 Jun 2025US 2025/0185656 A1Adeka Corporation
- Nitrogen-containing heterocyclic compound having nrf2 activation effect29 May 2025US 2025/0171457 A1Chugai Seiyaku Kabushiki Kaisha
- Nitrogen-containing heterocyclic compound having nrf2 activation effect13 Mar 2025US 2025/0084093 A1
Most cited
By later US patents
- Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits87US 6,417,178 B1University of Pittsburgh · 2002
- Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition71US 6,168,776 AUniversity of Pittsburgh · 2001
- Herbicides64US 6,894,005 B1Syngenta Crop Protection AG · 2005
- 7-(substituted)-8-(substituted)-9-[(substituted glycyl) amido]-6-demethyl-6-deoxytetracyclines53US 5,386,041 AAmerican Cyanamid Company · 1995
- Non-steroidal progesting52US 7,388,006 B2Bayer Schering Pharma Aktiengesellschaft · 2008